1.38 USD
▲+0.04+2.99%
盘后 1.42 0.00%
2026-09-16
市值
$85.16M
市盈率
—
EPS
-0.61
股息率
—
52 周区间
0.87 – 3.19
成交量
626.30K
Beta
0.26
目标价
12.00
52W 低 0.8752W 高 3.19
价格走势
公司简介
MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.